The Politics Behind the Pipeline: How MFN Pricing and Tariffs Are Reshaping Pharma's Global Strategy

About this episode

The episode discusses how US pricing policy and European legislative fragmentation are impacting pharmaceutical manufacturing strategies.

A panel discussion with Cristoffer Frendesen , EU Correspondent at Dagens Pharma, and Gil Roth , President of the Pharma and Biopharma Outsourcing Association, at CDMO Live Europe 2026, examined how US pricing policy, European legislative fragmentation, and FDA staffing gaps are forcing the industry to rethink where and how it manufactures. Read more.

People in this episode

Guests: Cristoffer Frendesen, Gil Roth

Topics covered

• pharmaceutical pricing
• global strategy
• manufacturing
• legislation
• FDA staffing
• tariffs

Keywords

• MFN pricing
• tariffs
• pharma strategy
• FDA
• manufacturing
• EU legislation
• pricing policy

Mentioned in this episode

Organizations: Dagens Pharma, Pharma and Biopharma Outsourcing Association, CDMO Live Europe 2026

Places: US, Europe

More episodes of PharmaSource Podcast

• How Sanofi Navigates Regulatory CMC Across Global Markets: Insights from Manda Pasarkar · June 11, 2026 · 31 min
• How to Build a Resilient Global Vaccine Supply Chain: From Crisis to Capability · June 4, 2026 · 46 min
• How Lonza Is Outgrowing the CDMO Market with Bioconjugation, AI, and Regionalization · May 31, 2026 · 29 min
• The Strategic Partnership Gap: Why CDMOs Are Meeting Pharma's Expectations Less Than Half the Time with Simon-Kucher · May 27, 2026 · 26 min
• Creative Financing Strategies for Biotech's Bear Market, Beyond the VC Round · May 25, 2026 · 29 min
• Decarbonizing Pharma: Why Green Chemistry Must Lead the Sustainability Agenda · May 18, 2026 · 27 min